Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer.

QN-165 - Qualigen Therap

http://www.ncbi.nlm.nih.gov/pubmed/38784467

Bo Xu; Qi Zhang; Xia Yuan; Xiang Li; Xiantao Yang; Xudong Sun; Yi Pan; Yuan Ma; Yuejie Zhu; Zhenjun Yang

May 24, 2024